Myriad(MYGN) - 2023 Q4 - Earnings Call Transcript

Myriad Genetics, Inc. (NASDAQ:MYGN) Q4 2023 Earnings Conference Call February 27, 2024 4:30 PM ET Company Participants Matt Scalo - Senior Vice President, Investor Relations Paul Diaz - President & Chief Executive Officer Mark Verratti - Chief Commercial Officer Sam Raha - Chief Operating Officer Scott Leffler - Chief Financial Officer Conference Call Participants Andrew Cooper - Raymond James Prashant Kota - Goldman Sachs Jack Meehan - Nephron Research David Westenberg - Piper Sandler Mason Carrico - Steph ...